Govt. descended Price of 126 drugs by 40%

New Delhi
Government has fixed the ceiling price of 530 essential medicines that has resulted in price reduction of over 40 per cent in case of 126 drugs, Parliament. “National Pharmaceutical Pricing Authority has fixed the ceiling price of 530 medicines”, out of 680 NLEM medicines (628 net medicines) that are under the scheduled category of DPCO 2013. Out of 530 drugs, above 40 per cent price reduction has happened in case of 126 medicines, while prices of 34 drugs has come down in the range of 35-40 per cent. The drug pricing regulator has reduced the price of 26 medicines by 30-35 per cent while prices of 49 drugs have been reduced in the range of 25-30 per cent. While the prices of 65 medicines have been reduced in the range of 20-25 per cent, 43 medicines have witnessed the price reduction in the range of 15 to 20 per cent. Moreover, 57 drugs saw price reduction of 10-15 per cent, price of 50 drugs were reduced in range of 5-10 per cent. In case of 80 medicines the reduction with respect to maximum price was between 0 to 5 per cent. NPPA mandate is to fix or revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country. It also monitors prices of decontrolled drugs in order to keep them at reasonable levels.

  • Related Posts

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi